Cyclacel pharmaceuticals reports third quarter results

Cyclacel pharmaceuticals reports third quarter 2019 financial results.cyclacel pharmaceuticals inc - qtrly loss per share $0.11.cyclacel pharmaceuticals inc - as of september 30, 2019, cash and cash equivalents totaled $13.0 million.

CYCC Ratings Summary

CYCC Quant Ranking